These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31618260)

  • 1. Clonality analysis of pulmonary tumors by genome-wide copy number profiling.
    Vincenten JPL; van Essen HF; Lissenberg-Witte BI; Bulkmans NWJ; Krijgsman O; Sie D; Eijk PP; Smit EF; Ylstra B; Thunnissen E
    PLoS One; 2019; 14(10):e0223827. PubMed ID: 31618260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers.
    Girard N; Ostrovnaya I; Lau C; Park B; Ladanyi M; Finley D; Deshpande C; Rusch V; Orlow I; Travis WD; Pao W; Begg CB
    Clin Cancer Res; 2009 Aug; 15(16):5184-90. PubMed ID: 19671847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonality assessment of multifocal lung adenocarcinoma by pathology evaluation and molecular analysis.
    Sun W; Feng L; Yang X; Li L; Liu Y; Lv N; Lin D
    Hum Pathol; 2018 Nov; 81():261-271. PubMed ID: 30420048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal Origin Evaluated by Trunk and Branching Drivers and Prevalence of Mutations in Multiple Lung Tumor Nodules.
    Rodriguez EF; Tseng LH; De Marchi F; Haung J; Belchis D; Xian R; Gocke CD; Eshleman JR; Illei PB; Lin MT
    Mol Diagn Ther; 2020 Aug; 24(4):461-472. PubMed ID: 32504414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines.
    Girard N; Deshpande C; Azzoli CG; Rusch VW; Travis WD; Ladanyi M; Pao W
    Chest; 2010 Jan; 137(1):46-52. PubMed ID: 19376842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically significant sub-clonality for common drivers can be detected in 26% of KRAS/EGFR mutated lung adenocarcinomas.
    Simon E; Bick T; Sarji S; Shentzer T; Prinz E; Yehiam L; Sabo E; Ben-Izhak O; Hershkovitz D
    Oncotarget; 2017 Jul; 8(28):45736-45749. PubMed ID: 28501852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics.
    Tan DS; Camilleri-Broët S; Tan EH; Alifano M; Lim WT; Bobbio A; Zhang S; Ng QS; Ang MK; Iyer NG; Takano A; Lim KH; Régnard JF; Tan P; Broët P
    Int J Cancer; 2014 Sep; 135(5):1092-100. PubMed ID: 24482041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Driver Mutation Analysis and PD-L1 Expression in Synchronous Double Primary Lung Cancer.
    Jia X; Zhang L; Wu W; Zhang W; Wu C
    Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):246-253. PubMed ID: 27438512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-Generation Sequencing: A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases.
    Patel SB; Kadi W; Walts AE; Marchevsky AM; Pao A; Aguiluz A; Mudalige T; Liu Z; Deng N; Lopategui J
    J Mol Diagn; 2017 Nov; 19(6):870-880. PubMed ID: 28866070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis.
    Takahashi Y; Shien K; Tomida S; Oda S; Matsubara T; Sato H; Suzawa K; Kurihara E; Ogoshi Y; Namba K; Yoshioka T; Torigoe H; Yamamoto H; Soh J; Toyooka S
    Cancer Sci; 2018 Nov; 109(11):3634-3642. PubMed ID: 30216592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
    Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization.
    Sawada T; Yamamoto E; Suzuki H; Nojima M; Maruyama R; Shioi Y; Akasaka R; Kamimae S; Harada T; Ashida M; Kai M; Adachi Y; Yamamoto H; Imai K; Toyota M; Itoh F; Sugai T
    Genes Chromosomes Cancer; 2013 Feb; 52(2):140-9. PubMed ID: 23073979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization.
    Kuroda A; Tsukamoto Y; Nguyen LT; Noguchi T; Takeuchi I; Uchida M; Uchida T; Hijiya N; Nakada C; Okimoto T; Kodama M; Murakami K; Matsuura K; Seto M; Ito H; Fujioka T; Moriyama M
    PLoS One; 2011; 6(7):e22313. PubMed ID: 21811585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma.
    van Rens MT; Eijken EJ; Elbers JR; Lammers JW; Tilanus MG; Slootweg PJ
    Cancer; 2002 Jan; 94(1):188-96. PubMed ID: 11815976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aspects of the clinicopathology and genetic profile of metachronous multiple lung cancers.
    Wu CT; Lin MW; Hsieh MS; Kuo SW; Chang YL
    Ann Surg; 2014 May; 259(5):1018-24. PubMed ID: 24368645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas.
    Hage M; Viengchareun S; Brunet E; Villa C; Pineau D; Bouligand J; Teglas JP; Adam C; Parker F; Lombès M; Tachdjian G; Gaillard S; Chanson P; Tosca L; Kamenický P
    J Clin Endocrinol Metab; 2018 May; 103(5):1929-1939. PubMed ID: 29474559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular analysis of synchronous double lung cancers.
    Arai J; Tsuchiya T; Oikawa M; Mochinaga K; Hayashi T; Yoshiura K; Tsukamoto K; Yamasaki N; Matsumoto K; Miyazaki T; Nagayasu T
    Lung Cancer; 2012 Aug; 77(2):281-7. PubMed ID: 22560922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite analysis of synchronous and metachronous tumors: a tool for double primary tumor and metastasis assessment.
    Tang M; Pires Y; Schultz M; Duarte I; Gallegos M; Wistuba II
    Diagn Mol Pathol; 2003 Sep; 12(3):151-9. PubMed ID: 12960697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.
    Fallet V; Saffroy R; Girard N; Mazieres J; Lantuejoul S; Vieira T; Rouquette I; Thivolet-Bejui F; Ung M; Poulot V; Schlick L; Moro-Sibilot D; Antoine M; Cadranel J; Lemoine A; Wislez M
    Ann Oncol; 2015 Aug; 26(8):1748-53. PubMed ID: 25969368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of second primary tumors from lung metastases in patients with esophageal squamous cell carcinoma using whole-exome sequencing.
    Xue L; Li W; Fan X; Zhao Z; Zhou W; Feng Z; Liu L; Lin H; Li L; Xue X; Huang X; Huang P; Guo J; Du P; Lu N; Li L; Zhan Q; Song Y
    Theranostics; 2020; 10(23):10606-10618. PubMed ID: 32929369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.